Expired European patentEurope
Use of taurolidine or taurultam for the manufacture of a medicament for the treatment of tumors of the central nervous system
EP 1797884 B1 · Applicant: RHODE ISLAND HOSPITAL
Overview
The published document from the EPO: abstract, claims, description and drawings. Open it full size
Read the whole patent
Listed from its EPO record in Patent Yard's archive of European patents past their term. Its claims, description and drawings are in the EPO PDF and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed December 6, 2000 and granted September 11, 2013. A European patent lasts at most 20 years from filing, so its term ended December 6, 2020.
- A supplementary protection certificate, which can extend a medicine or crop-protection patent, adds at most five and a half years, so even that would have ended by June 6, 2026.
- We check European rights only. A US or other national patent in its family could still be in force: check its family on Espacenet or Google Patents.
FiledDecember 6, 2000
PublishedJune 20, 2007
GrantedSeptember 11, 2013
Term endedDecember 6, 2020
Application numberEP 06019082
Classification (CPC)A61K31/16 +2 more
Timeline
Timeline From EPO dates
Sources & verification
Official EPO records
Everything on this page comes from the EPO record linked above. EPO data used under CC BY 4.0.